DBV Technologies Overview

  • Founded
  • 2002
Founded
  • Status
  • Public
  • Employees
  • 311
Employees
  • Stock Symbol
  • DBV
Stock Symbol
  • Share Price
  • $13.35
  • (As of Wednesday Closing)

DBV Technologies General Information

Description

DBV Technologies SA is a biotechnology company that provides therapy for food and pediatric allergy patients. The company focuses on discovering, developing, manufacturing, and commercializing treatments for severe allergies in the United States and other global markets. DBV's method of delivering biologically active compounds to the immune system is through self-administered and noninvasive products. The company also explores potential applications of its platform in vaccines and other immune diseases.

Contact Information

Website
www.dbv-technologies.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
PAR
Primary Office
  • 177-181 Avenue Pierre Brossolette
  • 92120 Montrouge
  • France
+33 01 00 00 00 00

DBV Technologies Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DBV Technologies Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$13.35 $12.51 $2.75 - $25.47 $732M 54.8M 1.65M -$3.69

DBV Technologies Financials Summary

In Thousands,
USD 		TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 320,913 941,131 135,824 1,027,095
Revenue 0 0 0 0
EBITDA (175,029) (163,439) (192,787) (160,208)
Net Income (177,299) (171,932) (195,981) (166,563)
Total Assets 337,012 270,495 196,464 213,315
Total Debt 25,360 27,634 4,385 5,507
Public Fundamental Data provided by Morningstar, Inc. disclaimer

DBV Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore DBV Technologies‘s full profile, request access.

Request a free trial

DBV Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
DBV Technologies SA is a biotechnology company that provides therapy for food and pediatric allergy patients. The compan
Biotechnology
Montrouge, France
311 As of 2019
00000
000000000 00000

000000

it, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
000000000000000
San Diego, CA
0 As of 0000
00.000
0000000000 0 00.000

000000

ur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mi
0000000000000
Lyon, France
000 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DBV Technologies Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Viriom Venture Capital-Backed San Diego, CA 0 00.000 0000000000 0 00.000
000000 Formerly VC-backed Lyon, France 000 000.00 00000000 000.00
0000000 0000000000 Formerly VC-backed Brisbane, CA 000 00000 000000&0 00000
0000000 Formerly VC-backed Summit, NJ 0000 000.00 000000&0 000.00
000000000 Formerly VC-backed South San Francisco, CA 00000 000.00 00000000000
You’re viewing 5 of 16 competitors. Get the full list »

DBV Technologies Executive Team (18)

Name Title Board Seat Contact Info
Daniel Tassé Chief Executive Officer
Sébastien Robitaille Chief of Staff & Chief Financial Officer
Ramzi Benamar Chief Financial Officer, Finance
Hugh Sampson MD Chief Scientific Officer
Wence Agbotounou Ph.D Chief Clinical Trial Officer
You’re viewing 5 of 18 executive team members. Get the full list »

DBV Technologies Board Members (11)

Name Representing Role Since
Daniel Soland Self Board Member 000 0000
Maïlys Ferrère Self Board Member 000 0000
Michael Goller DBV Technologies Board Member 000 0000
Michel De Rosen DBV Technologies Chairman & Board Member 000 0000
Torbjörn Bjerke MD Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

DBV Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DBV Technologies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore DBV Technologies‘s full profile, request access.

Request a free trial